Delivery Order SPE2DB20D2104-SPE2DB25FMRDF

Award Date 5/16/25
Potential Completion Date 5/19/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,351.83 firm fixed-price contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product. The contract has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,796.72 firm-fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. The contract has an ultimate completion date of May 16, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,082.84 firm fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medications, with a period of performance through June 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which...
This is a $9,065.17 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICK, a medication, with a period of performance through June 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,562.13 firm fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK medication. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,909.24, is for the supply of REPATHA 140 MG/ML SURECLICK medication. The order is a firm-fixed-price contract with an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $4,165.68 firm fixed-price delivery order is for the supply of REPATHA 140 MG/ML SURECLICK medication, with a period of performance through June 13, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The $2,629.95 firm fixed-price contract has an ultimate completion date of December 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,923.56 firm fixed-price contract is for the delivery of REPATHA 140 MG/ML SURECLICK ML, a medication, with a performance period through May 29, 2025. The award is not set-aside. Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty medication, with a firm fixed price ceiling value of $1,467.09 and an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMRDF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,219.59 firm fixed-price contract is for the supply of REPATHA 140 MG/ML SURECLICK ML, a pharmaceutical product. The contract has an ultimate completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract is not designated as a set-aside.

Generated 8/15/25, 9:48 AM